TY  - JOUR
T1  - NIh program helps developers navigate path to new drugs for neglected diseases
AU  - Voelker R
Y1  - 2012/02/08
N1  - 10.1001/jama.2012.83
JO  - JAMA
SP  - 549
EP  - 550
VL  - 307
IS  - 6
N2  - 
Since 2009, the NIH's Therapeutics for Rare and Neglected Diseases (TRND) program has solicited proposals from scientists and pharmaceutical companies trying to navigate that dead zone between discovering promising compounds and getting them into human clinical trials. To date, TRND has received 125 applications for nonmonetary assistance; 10 have gotten the green light. 

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.83
UR  - http://dx.doi.org/10.1001/jama.2012.83
ER  -